Trials / Completed
CompletedNCT01580384
A Non-Drug Study of The Suitability of Neurocognitive Tests And Functioning Scales For The Measurement of Cognitive And Functioning Changes in Individuals With Down Syndrome
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 90 (actual)
- Sponsor
- Hoffmann-La Roche · Industry
- Sex
- All
- Age
- 12 Years – 30 Years
- Healthy volunteers
- Not accepted
Summary
This non-drug, longitudinal, multi-center, multi-national study will evaluate the suitability of neurocognitive tests and functioning scales for the measurement of cognitive and functioning changes in individuals with Down Syndrome. Tests will be administered at clinic visits in Weeks 1, (4) and 24. The duration of the study for each individual will be between 24 and 27 weeks.
Conditions
Timeline
- Start date
- 2012-02-01
- Primary completion
- 2014-01-01
- Completion
- 2014-01-01
- First posted
- 2012-04-19
- Last updated
- 2015-03-03
Locations
12 sites across 7 countries: United States, Argentina, Canada, France, Italy, Spain, United Kingdom
Source: ClinicalTrials.gov record NCT01580384. Inclusion in this directory is not an endorsement.